3rd generation glp-1 Comment “Curious” for the deep dive. Retatrutide — a.k.a. “Reta” or “GLP-3” — is being called a future “trillion-dollar drug” and a revolution in fat loss. Retatrutide is a third-generation GLP-1–based drug. ( 🧬 R3TA is a next-generation

Although glucose-independent mechanisms are also emphasized, the antihyperglycemic effects of GLP-1 receptor agonists are thought to contribute to their nephroprotective effects in patients with DKD

The rapid proliferation of tumors requires an increased metabolic rate, which is mainly maintained by mitochondrial respiration, leading to an increased production of reactive oxygen species (ROS) [9]

They are not intended for human or veterinary use, medical advice, dosing, administration, treatment, or promised outcomes

Store the reconstituted solution in the refrigerator at 2C to 8C and use within 30 days

Public awareness campaigns must demystify GLP-1s: educate via TV, social media, and clinics that they're not "magic pens" but supervised therapies